| Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS (NCT05379985) | Revolution Medicines, Inc. | 2022-05-31 |
| Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation (NCT05198934) | Amgen | 2022-04-19 |
| Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors (NCT05176483) | Exelixis | 2021-12-14 |
| Collection of Samples USOPTIVAL Study (NCT04792684) | Universal Diagnostics | 2020-12-30 |
| Spanish Registry of Digestive Tumours RETUD (NCT06711211) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2020-12-23 |
| Advanced Therapies for Liver Metastases (NCT04622423) | IRCCS San Raffaele | 2019-11-06 |
| GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors (NCT04083599) | Genmab | 2019-09-17 |
| Clinical Characteristics and Prognosis of Simultaneous Versus Delayed Resection for Synchronous Colorectal Liver Metastasis: A Nationwide Multicenter Study Utilizing Propensity Score Matching Analysis (NCT07082335) | Shanghai 10th People's Hospital | 2019-01-01 |
| A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors (NCT03811652) | MedImmune LLC | 2018-12-20 |
| A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors (NCT03314935) | Incyte Corporation | 2017-11-21 |
| A Study of SC-007 in Subjects With Advanced Cancer (NCT03253185) | AbbVie | 2017-09-13 |
| An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib (NCT02955940) | Incyte Corporation | 2016-11-30 |
| Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors (NCT02903914) | Incyte Corporation | 2016-09-14 |
| Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors (NCT02646748) | Incyte Corporation | 2016-01-25 |
| Robot-assisted Surgery for Colorectal Cancer Resection: A Population-based Analysis of Prevalence, Trends and Outcomes (NCT06959849) | Medizinische Hochschule Brandenburg Theodor Fontane | 2016-01-01 |
| A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) (NCT02327078) | Incyte Corporation | 2014-11-26 |
| A Novel Patent Platform of Detection of Circulating Tumor Cells to Early Detect Colorectal Cancer Recurrence (NCT02005913) | National Taiwan University Hospital | 2014-01-01 |
| Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer (NCT00851045) | Bristol-Myers Squibb | 2009-10-01 |
| Adherence to a Recommended Exercise Regimen in Colorectal Cancer Patients (NCT00977613) | Beth Israel Medical Center | 2007-04-01 |
| Study of NGR-hTNF as Single Agent in Patients Affected by Colorectal Cancer (CRC) (NCT00483080) | AGC Biologics S.p.A. | 2006-12-01 |
| Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer (NCT00165854) | Eisai Limited | 2003-03-01 |
| Trends and Short-term Outcomes of Surgically Resected Early-onset Colorectal Cancer in Switzerland Between 2003 and 2022 (NCT07763314) | Cantonal Hospital of St. Gallen | 2003-01-01 |
| A Retrospective Study Comparing the Incidence of Parastomal Hernia After Mesenteric Molding Suturing and Non-molding Suturing in Colostomy Surgery (NCT06674200) | The First Affiliated Hospital with Nanjing Medical University | 2002-01-01 |
| Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval (NCT06751524) | Agenus Inc. | |